VEGFA and retinopathy of prematurity: Similarly, Fan et al. reported that miR-126 inhibited pathological retinal angiogenesis in a retinopathy of prematurity in an in vivo model, demonstrating its potential to suppress VEGFA-driven neovascular growth [40].